These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 15158945)

  • 1. Poly-epsilon-caprolactone microspheres and nanospheres: an overview.
    Sinha VR; Bansal K; Kaushik R; Kumria R; Trehan A
    Int J Pharm; 2004 Jun; 278(1):1-23. PubMed ID: 15158945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New self-nanoemulsifying drug delivery system (SNEDDS) with amphiphilic diblock copolymer methoxy poly (ethylene glycol)-block-poly (ε-caprolactone).
    Ren F; Gao Y; Chen J; Jing Q; Yu Y
    Pharm Dev Technol; 2013; 18(3):745-51. PubMed ID: 23477527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microspheres made of poly(epsilon-caprolactone)-based amphiphilic copolymers: potential in sustained delivery of proteins.
    Quaglia F; Ostacolo L; Nese G; De Rosa G; La Rotonda MI; Palumbo R; Maglio G
    Macromol Biosci; 2005 Oct; 5(10):945-54. PubMed ID: 16208680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of poly-epsilon-caprolactone nanospheres coated with bioadhesive hyaluronic acid for ocular delivery.
    Barbault-Foucher S; Gref R; Russo P; Guechot J; Bochot A
    J Control Release; 2002 Oct; 83(3):365-75. PubMed ID: 12387945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colchicine encapsulation within poly(ethylene glycol)-coated poly(lactic acid)/poly(epsilon-caprolactone) microspheres-controlled release studies.
    Das GS; Rao GH; Wilson RF; Chandy T
    Drug Deliv; 2000; 7(3):129-38. PubMed ID: 10989913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro studies on the release of isoniazid incorporated in poly(epsilon-caprolactone).
    Durán N; De Oliveira AF; De Azevedo MM
    J Chemother; 2006 Oct; 18(5):473-9. PubMed ID: 17127222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances in Application of Poly-Epsilon-Caprolactone and its Derivative Copolymers for Controlled Release of Anti-Tumor Drugs.
    Sun Z; Duan R; Xing D; Pang X; Li Z; Chen X
    Curr Cancer Drug Targets; 2017; 17(5):445-455. PubMed ID: 28067177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of pendant hydroxyl groups on enzymatic degradation and drug delivery of amphiphilic poly[glycidol-block-(epsilon-caprolactone)] copolymers.
    Mao J; Gan Z
    Macromol Biosci; 2009 Nov; 9(11):1080-9. PubMed ID: 19634151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular uptake and concentrations of tamoxifen upon administration in poly(epsilon-caprolactone) nanoparticles.
    Chawla JS; Amiji MM
    AAPS PharmSci; 2003; 5(1):E3. PubMed ID: 12713275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, optimization and evaluation of poly-ε-caprolactone (PCL) based polymeric nanoparticles for oral delivery of lopinavir.
    Ravi PR; Vats R; Dalal V; Gadekar N; N A
    Drug Dev Ind Pharm; 2015 Jan; 41(1):131-40. PubMed ID: 24180260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticles obtained by confined impinging jet mixer: poly(lactide-co-glycolide) vs. Poly-ε-caprolactone.
    Turino LN; Stella B; Dosio F; Luna JA; Barresi AA
    Drug Dev Ind Pharm; 2018 Jun; 44(6):934-941. PubMed ID: 29300113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microparticles of Lamivudine-Poly-ε-Caprolactone Conjugate for Drug Delivery via Internalization by Macrophages.
    Urbaniak T; Machová D; Janoušková O; Musiał W
    Molecules; 2019 Feb; 24(4):. PubMed ID: 30781578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine tuning micellar core-forming block of poly(ethylene glycol)-block-poly(ε-caprolactone) amphiphilic copolymers based on chemical modification for the solubilization and delivery of doxorubicin.
    Yan J; Ye Z; Chen M; Liu Z; Xiao Y; Zhang Y; Zhou Y; Tan W; Lang M
    Biomacromolecules; 2011 Jul; 12(7):2562-72. PubMed ID: 21598958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, characterization, and degradation behavior of amphiphilic poly-alpha,beta-[N-(2-hydroxyethyl)-L-aspartamide]-g-poly(epsilon-caprolactone).
    Miao ZM; Cheng SX; Zhang XZ; Zhuo RX
    Biomacromolecules; 2005; 6(6):3449-57. PubMed ID: 16283778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro evaluation of effects of sustained anti-TNF release from MPEG-PCL-MPEG and PCL microspheres on human rheumatoid arthritis synoviocytes.
    Erdemli Ö; Özen S; Keskin D; Usanmaz A; Batu ED; Atilla B; Tezcaner A
    J Biomater Appl; 2014 Oct; 29(4):524-42. PubMed ID: 24854983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability and in vitro drug release of flurbiprofen-loaded poly-epsilon-caprolactone nanospheres.
    Lacoulonche F; Gamisans F; Chauvet A; García ML; Espina M; Egea MA
    Drug Dev Ind Pharm; 1999 Sep; 25(9):983-93. PubMed ID: 10518238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degradation and cell culture studies on block copolymers prepared by ring opening polymerization of epsilon-caprolactone in the presence of poly(ethylene glycol).
    Huang MH; Li S; Hutmacher DW; Schantz JT; Vacanti CA; Braud C; Vert M
    J Biomed Mater Res A; 2004 Jun; 69(3):417-27. PubMed ID: 15127388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spray coating of foley urinary catheter by chlorhexidine-loadedpoly(ε-caprolactone) nanospheres: effect of lyoprotectants, characteristics, and antibacterial activity evaluation.
    Srisang S; Nasongkla N
    Pharm Dev Technol; 2019 Apr; 24(4):402-409. PubMed ID: 30265590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer drug-loaded nanospheres based on biodegradable amphiphilic ε-caprolactone and carbonate copolymers.
    Yan GP; Zong RF; Li L; Fu T; Liu F; Yu XH
    Pharm Res; 2010 Dec; 27(12):2743-52. PubMed ID: 20859660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidance of glial cell migration and axonal growth on electrospun nanofibers of poly-epsilon-caprolactone and a collagen/poly-epsilon-caprolactone blend.
    Schnell E; Klinkhammer K; Balzer S; Brook G; Klee D; Dalton P; Mey J
    Biomaterials; 2007 Jul; 28(19):3012-25. PubMed ID: 17408736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.